Barry Greene

Chief Executive Officer at SAGE Therapeutics, Inc.

Barry Greene

Barry Greene

Chief Executive Officer at SAGE Therapeutics, Inc.

Overview
Career Highlights

Alnylam Pharmaceuticals, Inc.
SAGE Therapeutics, Inc.
Vicarious Surgical, Inc.

RelSci Relationships

3496

Number of Boards

10

Birthday

1964

Age

57

Contact Data
Trying to get in touch with Barry Greene? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Barry Greene likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Karyopharm Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Executive Vice President, Chief Legal Officer & Secretary at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Vice President of Research & RLD at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Acorda Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Barry Greene
Potential Connections via
Relationship Science
You
Barry Greene
Chief Executive Officer at SAGE Therapeutics, Inc.
Education
BS in Industrial Engineering

The University of Pittsburgh is among the nation's oldest and most distinguished comprehensive universities, with a wide variety of high-quality programs in the arts and sciences as well as professional fields. Pitt is a member of the Association of American Universities (AAU), which comprises 62 preeminent doctorate-granting research institutions in North America

Career History
Chief Executive Officer
2020 - Current

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Fund Advisor
Current

Longwood Fund Management invests in companies located in the US. The firm targets companies operating in the fields healthcare and science companies. They provides financing for early stage capital requirements.

Co-Founder
2014 - Prior

Vicarious Surgical, Inc. engages in the development of human-like surgical robotics. It creates virtual reality software for minimally invasive surgery procedures. The company was founded by Adam Sachs, Barry E. Greene and Sammy Khalifa in 2014 and is headquartered in Charlestown, MA.

Boards & Committees
Director
2011 - 2012

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Political Donations
$1,000
2010

Government Affairs at Pax Labs, Inc.

Investments
Details Hidden

Vicarious Surgical, Inc. engages in the development of human-like surgical robotics. It creates virtual reality software for minimally invasive surgery procedures. The company was founded by Adam Sachs, Barry E. Greene and Sammy Khalifa in 2014 and is headquartered in Charlestown, MA.

Details Hidden

Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Barry Greene. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Barry Greene's profile does not indicate a business or promotional relationship of any kind between RelSci and Barry Greene.